[1] 董梦珍,林中华,刘守胜,等.AGT rs5051基因多态性增加中国汉族人群非ALD患者发生冠心病的风险.中华肝脏病杂志,2021,29(11):1095-1100. [2] Astarini FD, Ratnasari N, Wasityastuti W , et al. Update on non-alcoholic fatty liver disease-associated single nucleotide polymorphisms and their involvement in liver steatosis, inflammation, and fibrosis: a narrative review. Iran Biomed J, 2022 ,26(4):252-268. [3] Adalı Y, Eroğlu HA, Makav M , et al. Comparison of tru-cut biopsy and fine-needle aspiration cytology in an experimental alcoholic liver disease model. Rev Assoc Med Bras (1992), 2020,66(8):1030-1035. [4] Steinkohl F, Barbieri F, Senoner T , et al. Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study. Eur Radiol, 2021 ,31(1):494-503. [5] Zhuge Q, Zhang Y, Liu B , et al. Blueberry polyphenols play apreventive effect on alcoholic fatty liver disease C57BL/6 J mice by promoting autophagy to accelerate lipolysis to eliminate excessive TG accumulation in hepatocytes. Ann Palliat Med, 2020,9(3):1045-1054. [6] Yaraş S, Sezgin O, Üçbilek E, et al. Significant decrease in liver stiffness detected by two dimensional shear-wave elastography after treatment with direct-acting antiviral agents in patients with chronic Hepatitis C. Turk J Gastroenterol, 2020 ,31(2):142-147. [7] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会. 酒精性肝病防治指南(2018年更新版). 实用肝脏病杂志,2018,21(2):170-176. [8] 中国肝炎防治基金会,中华医学会感染病学分会,中华医学会肝病学分会和中国研究型医院学会肝病专业委员会.瞬时弹性成像技术诊断肝纤维化专家共识(2018年更新版).中华肝脏病杂志,2019,27(3):182-191. [9] 王琳,林雪松,丁楠.非酒精性单纯性脂肪肝与非酒精性脂肪性肝炎患者血清脂质组学比较.实用肝脏病杂志,2022,25(2):215-218. [10] 陈永超,周旺,李岩,等.超声造影指导肝穿刺对肝脏占位性病变的诊断价值研究.实用肝脏病杂志,2021,24(4):569-572. [11] Iwashita H, Shakado S, Yoshimaru N , et al. Clinical utility of ultrasound-guided attenuation parameter for the detection and quantification of hepatic steatosis in patients with fatty liver diagnosed by computed tomography. Ultrasound Med Biol, 2022 ,48(7):1282-1289. [12] Saraireh H, Abdelfattah T, Hassouneh R , et al. "Wet heparin" and "wet saline" EUS-guided liver biopsy techniques both provide high rates of specimen adequacy for benign parenchymal liver disease. Dig Dis Sci, 2022,67(11):5256-5261. [13] Bende F, Sporea I,Şirli R , et al. Ultrasound-guided attenuation parameter (UGAP) for the quantification of liver steatosis using the controlled attenuation parameter (CAP) as the reference method. Med Ultrason, 2021,23(1):7-14. [14] Rodina AS, Shubina ME, Kurbatova IV , et al. Hepatocytic apoptosis and immune dysfunction in decompensation of alcoholic liver cirrhosis with different grades of acute-on-chronic liver failure. Bull Exp Biol Med, 2022 ,172(4):410-414. [15] Sisman G, Barbur E, Saka D , et al. Endoscopic ultrasound-guided liver biopsy using a 20-gauge fine needle biopsy needle with the wet-heparinized suction technique. Eur J Gastroenterol Hepatol, 2020,32(11):1470-1474. [16] Cannella R, Dasyam N, SeoSH , et al. Performance of morphologic criteria for the diagnosis of cirrhosis in patients with non-alcoholic steatohepatitis compared to other etiologies of chronic liver disease: effect of level of training and experience. Abdom Radiol (NY), 2021 ,46(3):960-968. [17] Kim D, Cholankeril G, Loomba R, et al. Prevalence of fatty liver disease and fibrosis detected by fibroscan in adults in the united states, 2017-2018. Clin Gastroenterol Hepatol, 2020, 19(7):1499-1501. [18] Xu Y, Liu Y, Cao Z, et al. Comparison of fibrotouch and fibroscan for staging fibrosis in chronic liver disease: single-center prospective study. Dig Liver Dis, 2019,51(9):1323-1329. [19] Cotter TG, Charlton MR. The triumph of bacchus: the emergence of nonalcoholic steatohepatitis and alcoholic liver disease as the leading causes of mortality from cirrhosis. Hepatology, 2019,69(3):931-933. [20] Meyer JJ, Dreyhaupt J, Schwerdel D , et al. Blood-based targeted metabolomics discriminate patients with alcoholic liver cirrhosis from those with non-cirrhotic liver damage: an explorative study. Dig Dis, 2022;40(2):223-231. |